Evaluating Treatment Options of EGFR Inhibitors

Opinion
Video

Dr. Garon explains the factors guiding his choice between EGFR inhibitors for EGFR+ NSCLC and when he might consider alternatives like afatinib or erlotinib.

MOTM24_CN_Lung2_Seg06_Evaluating
Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Video content above is prompted by the following:

      • What factors guide your choice, and in which cases might you consider alternatives like afatinib or erlotinib?
      Related Content